BMA reveals new chief executive and chairman of board
The Bermuda Monetary Authority (BMA) has appointed a new chief executive officer and chairman of the board of directors, respectively.
Craig Swan (pictured) has stepped into the role of CEO, after serving as deputy CEO of the BMA since January 2020, a position created to fulfil the BMA’s strategic objective of succession planning as the Authority prepared for executive chairman Jeremy Cox’s departure in 2021.
Donald Scott has been appointed as chairman of the board. He has held the position of deputy chair of the Authority’s Board since 2019. During this time, he has served on several Board committees, including the Corporate Governance and Ethics Committee, Human Capital Committee, Legislative and Policy Committee and non-executive directors Committee.
Prior to his appointment to the board, Scott’s 30-year career was Bermuda-focused, working in Government in the technical areas of gross domestic product and national income compilation and also in the policy areas of economics, finance and health.
Commenting on his transition into this new role as chairman, Scott said: “For nearly three years, I had the pleasure of serving as the Authority’s Deputy Chair, during which time I have had the benefit of working closely with Executive Chairman Mr. Jeremy Cox, as well as the other highly skilled and deeply experienced Directors on the BMA’s Board. I look forward to further fostering this collaboration with each of these Directors and the wider BMA team as we continue to fulfil our mandate as Bermuda’s independent regulator of all financial services.”
Swan added: “The BMA has been, and will remain, a responsible regulator, developing, enhancing and administering clear, pragmatic and prudent regulatory frameworks and supervisory approaches. This role has always come with its challenges.
“Going forward, the BMA will maintain its steadfast dedication to proactive supervision and regulation. Contributing to the development of global regulatory standards, rapidly coming to grips with emerging risks, utilising technology and coordinating and collaborating with peer regulators will remain a focus. This will be highlighted in the upcoming 2022 Business Plan, particularly the manner in which innovation will continue to drive the BMA and its operations forward.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
